Warfarin Therapeutic Response Predictive Assay VKORC1 CYP2C9
The Warfarin Therapeutic Response Predictive Assay VKORC1 CYP2C9 is a specialized genetic test designed to assess how individuals metabolize Warfarin, a widely used anticoagulant medication. Understanding your genetic profile can significantly enhance the safety and efficacy of Warfarin therapy, minimizing the risk of adverse reactions and ensuring optimal dosing.
What This Test Measures
This assay evaluates specific genetic variations in the VKORC1 and CYP2C9 genes, which are crucial for determining how your body processes Warfarin. Variations in these genes can lead to differences in drug efficacy and the risk of bleeding complications.
Who Should Consider This Test?
- Patients currently prescribed Warfarin for anticoagulation therapy.
- Individuals with a history of adverse reactions to Warfarin.
- Patients undergoing treatment for conditions that require careful management of blood coagulation, such as atrial fibrillation or venous thromboembolism.
Benefits of Taking the Test
- Personalized treatment: Tailor Warfarin dosing based on your genetic makeup.
- Reduced risk of complications: Minimize the likelihood of bleeding or clotting events.
- Improved therapeutic outcomes: Achieve optimal anticoagulation levels more efficiently.
Understanding Your Results
Results from the Warfarin Therapeutic Response Predictive Assay VKORC1 CYP2C9 will provide insights into your genetic predisposition to Warfarin metabolism. Your healthcare provider will interpret these results to guide your treatment plan effectively.
Test Details and Pricing
Test Name | Discount Price | Regular Price |
---|---|---|
Warfarin Therapeutic Response Predictive Assay VKORC1 CYP2C9 | 120000 NGN | 160000 NGN |
Booking the Test
To book the Warfarin Therapeutic Response Predictive Assay VKORC1 CYP2C9, please call or WhatsApp us at +2348077798758. Ensure you have a doctor’s prescription for this test, which is not applicable for surgery or pregnancy cases, or for individuals planning to travel abroad.
Turnaround time for results is approximately 3-4 days, and the sample type required is peripheral blood collected in an EDTA Vacutainer (2ml).
Take the first step towards personalized healthcare today!